Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Long-term follow-up of patients with hepatitis B e antigen negative chronic hepatitis B.

Journal of gastroenterology and hepatology - 1 Jan 2011

Bekku Dan, Arai Makoto, Imazeki Fumio, Yonemitsu Yutaka, Kanda Tatsuo, Fujiwara Keiichi, Fukai Kenichi, Sato Kenichi, Itoga Sakae, Nomura Fumio, Yokosuka Osamu

Abstract excerpt

BACKGROUND AND AIM: After hepatitis B virus (HBV) e antigen (HBeAg) seroconversion, HBV-DNA continues to replicate, and HBeAg-negative patients still face the risk of liver disease progression. We investigated the predictive factors for alanine aminotransferase (ALT) elevation, antiviral drug use, and hepatocellular carcinoma (HCC) occurrence in HBeAg-negative patients. METHODS: Age, sex, ALT, platelet counts,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alanine Transaminase
Share to Carcinoma, Hepatocellular

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chi-Square Distribution

Share to Hepatitis B, Chronic

Share to Hepatitis B e Antigens

Share to Kaplan-Meier Estimate

Share to Platelet Count

Share to Proportional Hazards Models

Source

Identifiers

PMID: 21175805
DOI: 10.1111/j.1440-1746.2010.06322.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Long-term follow-up of patients with hepatitis B e antigen negative chronic hepatitis B.PMID 21175805Read ↗

Hepatocellular Carcinoma Risk Steadily Persists over Time Despite Long-Term Antiviral Therapy for Hepatitis B: A Multicenter Study.Semantic proximity Read ↗

Management of chronic hepatitis B: status and challenges beyond treatment guidelines.Semantic proximity Read ↗

Hepatitis B virus DNA prediction rules for hepatitis B e antigen-negative chronic hepatitis B.Semantic proximity Read ↗

Predictive factors for reactivation of hepatitis B following hepatitis B e antigen seroconversion in chronic hepatitis B.Semantic proximity Read ↗

Reduction of hepatitis B surface antigen levels and hepatitis B surface antigen seroclearance in chronic hepatitis B patients receiving 10 years of nucleoside analogue therapy.Semantic proximity Read ↗

Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma.Semantic proximity Read ↗

Large spontaneous HBV DNA fluctuations and potential usefulness of a single point measurement of combined HBV DNA and quantitative HBsAg for the exclusion of HBeAg negative chronic hepatitis B: A prospective Tunisian cohort studySemantic proximity Read ↗

Influential factors of prognosis in lamivudine treatment for patients with acute-on-chronic hepatitis B liver failure.Semantic proximity Read ↗

Longitudinal change of HBsAg in HBeAg-negative patients with genotype B or C infection.Semantic proximity Read ↗

Nucleos(t)ide Analogue Treatment for Patients With Hepatitis B Virus (HBV) e Antigen-Positive Chronic HBV Genotype C Infection: A Nationwide, Multicenter, Retrospective Study.Semantic proximity Read ↗

Sustained antiviral effects and clearance of hepatitis surface antigen after combination therapy with entecavir and pegylated interferon in chronic hepatitis B.Semantic proximity Read ↗

Long-term follow-up of Japanese patients with chronic hepatitis B treated with interferon-alpha.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.